Potency of tenofovir in chronic hepatitis B: mono or combination therapy?

J Hepatol. 2008 Mar;48(3):383-6. doi: 10.1016/j.jhep.2007.12.006. Epub 2007 Dec 31.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Antiviral Agents / therapeutic use
  • DNA, Viral / blood
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Drug Therapy, Combination
  • Emtricitabine
  • Guanine / analogs & derivatives
  • Guanine / therapeutic use
  • Hepatitis B / genetics
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Lamivudine / therapeutic use
  • Organophosphonates / therapeutic use*
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Tenofovir
  • Treatment Outcome
  • Viral Load

Substances

  • Antiviral Agents
  • DNA, Viral
  • Organophosphonates
  • Reverse Transcriptase Inhibitors
  • Deoxycytidine
  • Lamivudine
  • entecavir
  • Guanine
  • Tenofovir
  • Emtricitabine
  • Adenine